EPHX2 and colorectal carcinoma: The clinical correlation between EPHX2 and CRC was explored, the inhibitory effect of EPHX2 on the progression of CRC was confirmed, and a real lipid metabolism model of colon cancer with the participation of EPHX2 was preliminarily established.